Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$1.49B |
| 2 |
Cloudflare
NET
|
+$1.3B |
| 3 |
Roblox
RBLX
|
+$1.1B |
| 4 |
Wayfair
W
|
+$1.05B |
| 5 |
Microsoft
MSFT
|
+$708M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.83B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.24B |
| 3 |
Amazon
AMZN
|
+$1.48B |
| 4 |
Intuitive Surgical
ISRG
|
+$1.39B |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$1.23B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.58% |
| 2 | Technology | 20.18% |
| 3 | Healthcare | 9.88% |
| 4 | Consumer Discretionary | 9.13% |
| 5 | Communication Services | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
376
Edwards Lifesciences
EW
$49.9B
| $332M | 0.04% |
3,204,206
+164,907
| +5% | +$15.5M |
2013 Q2
32 quarters
|
|
377
Rio Tinto
RIO
$147B
| $330M | 0.04% |
3,931,625
+2,673,607
| +213% | +$230M |
2013 Q2
32 quarters
|
|
378
Vanguard Total World Stock ETF
VT
$81.3B
| $330M | 0.04% |
3,182,736
+37,083
| +1% | +$3.78M |
2013 Q2
32 quarters
|
|
379
Southern Company
SO
$105B
| $329M | 0.04% |
5,433,970
+1,064,450
| +24% | +$68.1M |
2013 Q2
32 quarters
|
|
380
Axon Enterprise
AXON
$31.7B
| $327M | 0.04% |
1,847,975
-616,197
| -25% | -$90.7M |
2013 Q2
32 quarters
|
|
381
NIO
NIO
$8.59B
| $325M | 0.04% |
6,112,718
+1,404,194
| +30% | +$56.2M |
2018 Q3
11 quarters
|
|
382
Vanguard Russell 1000 Growth ETF
VONG
$45.7B
| $320M | 0.04% |
4,585,060
+33,408
| +0.7% | +$2.22M |
2013 Q2
32 quarters
|
|
383
Clorox
CLX
$10.5B
| $320M | 0.04% |
1,777,850
+917,080
| +107% | +$167M |
2013 Q2
32 quarters
|
|
384
Alnylam Pharmaceuticals
ALNY
$31B
| $319M | 0.04% |
1,882,651
+96,697
| +5% | +$14.2M |
2013 Q2
32 quarters
|
|
385
JD.com
JD
$36.5B
| $318M | 0.04% |
3,985,860
+1,504,113
| +61% | +$113M |
2014 Q2
28 quarters
|
|
|
XLNX
386
DELISTED
Xilinx Inc
XLNX
| $317M | 0.04% |
2,194,429
-94,950
| -4% | -$12.1M |
2013 Q2
32 quarters
|
|
387
iShares Russell 1000 ETF
IWB
$48.7B
| $317M | 0.04% |
1,310,457
+3,219
| +0.2% | +$758K |
2013 Q2
32 quarters
|
|
388
Factset
FDS
$10.7B
| $317M | 0.04% |
944,784
+62,164
| +7% | +$20.4M |
2013 Q2
32 quarters
|
|
|
ALXN
389
DELISTED
Alexion Pharmaceuticals
ALXN
| $317M | 0.04% |
1,725,693
-74,500
| -4% | -$12.8M |
2013 Q2
32 quarters
|
|
390
VanEck Morningstar Wide Moat ETF
MOAT
$11.7B
| $316M | 0.04% |
4,262,180
+239,906
| +6% | +$17.5M |
2013 Q2
32 quarters
|
|
391
Agilon Health
AGL
$1.43B
| $315M | 0.04% |
+310,415
| New | +$272M |
2021 Q2
0 quarters
|
|
392
Peloton Interactive
PTON
$2.29B
| $315M | 0.04% |
2,538,190
+167,461
| +7% | +$17.8M |
2019 Q3
7 quarters
|
|
393
Newmont
NEM
$125B
| $314M | 0.04% |
4,948,042
+179,707
| +4% | +$12M |
2013 Q2
32 quarters
|
|
394
Sunrun
RUN
$1.76B
| $312M | 0.04% |
5,592,845
+1,298,761
| +30% | +$62.7M |
2015 Q3
23 quarters
|
|
395
SBA Communications
SBAC
$19.8B
| $310M | 0.04% |
971,938
+417,168
| +75% | +$125M |
2013 Q2
32 quarters
|
|
396
Invesco Ultra Short Duration ETF
GSY
$3.86B
| $309M | 0.04% |
6,117,047
+101,972
| +2% | +$5.15M |
2018 Q2
12 quarters
|
|
397
First Trust Dorsey Wright Focus 5 ETF
FV
$3.81B
| $307M | 0.04% |
6,483,573
+313,039
| +5% | +$14.5M |
2014 Q1
29 quarters
|
|
398
Vanguard Health Care ETF
VHT
$19.8B
| $307M | 0.04% |
1,242,908
+32,528
| +3% | +$7.77M |
2013 Q2
32 quarters
|
|
399
Marriott International
MAR
$101B
| $306M | 0.04% |
2,239,597
+262,067
| +13% | +$37.8M |
2013 Q2
32 quarters
|
|
|
CVET
400
DELISTED
Covetrus, Inc. Common Stock
CVET
| $306M | 0.04% |
11,319,745
+145,888
| +1% | +$4.08M |
2019 Q1
9 quarters
|
|
Similar funds
Morgan Stanley's Q2 2021 Portfolio in Review
As of Q2 2021, Morgan Stanley held 8,036 positions worth $758B, up 11% from $681B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley deployed $26.3B of net new capital in Q2 2021, opening 455 new positions and adding to 4,494 existing holdings. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 49,152,168 shares worth $695M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 30% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $6.83B trimmed.
- Morgan Stanley's largest Q2 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 49,152,168 shares worth $695M.
- Morgan Stanley added most to Vanguard Total Bond Market in Q2 2021, an estimated $1.49B increase.
- Morgan Stanley's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.83B.
- Morgan Stanley fully exited RealPage, Inc. in Q2 2021, selling an estimated $193M.
- Morgan Stanley's ten largest holdings make up 15% of its $758B portfolio in Q2 2021.
- Morgan Stanley opened 455 new positions and closed 220 in Q2 2021.
- Morgan Stanley's portfolio value rose 11% quarter-over-quarter to $758B.
Based on Morgan Stanley's 13F filing for Q2 2021, filed 16 Aug 2021.